Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.15EUR
87.53 MEUR
522.53 MEUR
310.16 M
About HYGEIA HEALTHCARE HLDGS CO LTD
Hygeia Healthcare Holdings Co., Ltd. operates as a biopharmaceutical company that focuses on the development of new clinical drugs. It operates through the following segments: Hospital Business, Radiotherapy Business, and Hospital Management Business. The Hospital Business segment operates through self-owned private for-profit hospitals which are variable interest entities owned by the group by undertaking group reorganization. The Radiotherapy Business segment offers licensing of radiotherapy equipment for use in the radiotherapy centres and provision of maintenance and technical support services in relation to radiotherapy equipment. The Hospital Management Business segment engages in provision of management services to private not-for-profit hospitals. The company was founded by Yiwen Zhu in 2009 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange HYGEIA HC HLDGS DL-,00001 stocks are traded under the ticker 50I.
We've gathered analysts' opinions on HYGEIA HC HLDGS DL-,00001 future price: according to them, 50I price has a max estimate of 5.34 EUR and a min estimate of 2.20 EUR. Watch 50I chart and read a more detailed HYGEIA HC HLDGS DL-,00001 stock forecast: see what analysts think of HYGEIA HC HLDGS DL-,00001 and suggest that you do with its stocks.
Yes, you can track HYGEIA HC HLDGS DL-,00001 financials in yearly and quarterly reports right on TradingView.
HYGEIA HC HLDGS DL-,00001 is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
50I earnings for the last half-year are 0.08 EUR per share, whereas the estimation was 0.08 EUR, resulting in a −7.58% surprise. The estimated earnings for the next half-year are 0.09 EUR per share. See more details about HYGEIA HC HLDGS DL-,00001 earnings.
HYGEIA HC HLDGS DL-,00001 revenue for the last half-year amounts to 305.90 M EUR, despite the estimated figure of 341.72 M EUR. In the next half-year revenue is expected to reach 395.36 M EUR.
50I net income for the last half-year is 49.81 M EUR, while the previous report showed 43.71 M EUR of net income which accounts for 13.96% change. Track more HYGEIA HC HLDGS DL-,00001 financial stats to get the full picture.
Yes, 50I dividends are paid annually. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (TTM)% is 0.92%. Tracking HYGEIA HC HLDGS DL-,00001 dividends might help you take more informed decisions.
HYGEIA HC HLDGS DL-,00001 dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.29% and 18.20% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 4, 2024, the company has 8.24 K employees. See our rating of the largest employees — is HYGEIA HC HLDGS DL-,00001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HYGEIA HC HLDGS DL-,00001 EBITDA is 155.07 M EUR, and current EBITDA margin is 25.36%. See more stats in HYGEIA HC HLDGS DL-,00001 financial statements.
Like other stocks, 50I shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HYGEIA HC HLDGS DL-,00001 stock right from TradingView charts — choose your broker and connect to your account.